Skip to content

Clinical Study on Evaluating Xerostomia and Sjögren's Syndrome Using Salivary Gland Elasticity

A clinical research to evaluate xerostomia and primary Sjögren's syndrome based on salivary gland Young's modulus values

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109458
Enrollment
Unknown
Registered
2025-09-18
Start date
2024-07-17
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerostomia

Interventions

Gold Standard:For participants with pathologically confirmed pSS: They must have clinical symptoms of dry mouth and meet the 2016 pSS diagnostic criteria set by the American College of Rheumatology (A
Index test:Ultrasound shear wave elastography

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Participants must be informed about the entire trial process, voluntarily agree to participate, and sign an informed consent form; 2.They must be aged >=18 years and <=75 years; 3.For suspected preclinical xerostomia participants: (1) They must have experienced symptoms of dry mouth for more than 3 months; (2) They must test negative for autoantibodies (SSA, SSB, RO52); (3) Their total score on the Xerostomia Inventory (XI) must be 6 or higher out of 10; 4.For participants with pathologically confirmed pSS: They must have clinical symptoms of dry mouth and meet the 2016 pSS diagnostic criteria set by the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR).

Exclusion criteria

Exclusion criteria: 1.Patients with severe hypertension, diabetes, or systemic rheumatic immune diseases; 2.Those taking medications that may cause dry mouth (e.g., furosemide); 3.Patients who have undergone radiotherapy for head and neck malignancies or chemotherapy for other systemic malignancies; 4.Pregnant women, those planning to become pregnant, or women who are breastfeeding; 5.Individuals with any other conditions that the researchers deem unsuitable for inclusion in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Stiffness of the parotid gland (kPa);

Secondary

MeasureTime frame
Stiffness of the submandibular gland (kPa);

Countries

China

Contacts

Public ContactYiwen Deng

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

sunny3311@sina.com+86 21 23271699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026